Collagens Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Collagens Pipeline Market Report Overview

Collagen dressings are typically made up of a combination of animal collagen and any other formulation for structural integrity, and sodium or calcium ions. These are available in many forms such as sheets, gels, pads, particles, and pastes. The Collagens pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Antimicrobial Collagen Dressings

·        Non-Antimicrobial Collagen Dressings

Key Territories ·        The US

·        Europe

·        China

·        Israel

·        Taiwan

Key Regulatory Paths ·        510(k)

·        CE

·        NMPA

·        BOPA

Leading Companies ·        Acro Biomedical Co Ltd

·        Advanced Biotech Products Pvt Ltd

·        Advanced Medical Solutions Group plc

·        AGAM Biological Products

·        Altach AG

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Collagens Pipeline Market by Segments

The key segments in the collagens pipeline market are antimicrobial collagen dressings and non-antimicrobial collagen dressings. As of December 2023, antimicrobial collagen dressings accounted for the highest number of pipeline products. Such collagen dressings contain an agent to inhibit microbial growth.

Collagens Pipeline Market Analysis by Segments, 2023 (%)

Collagens Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Collagens Pipeline Market

Download a Free Report Sample

Collagens Pipeline Market Segmentation by Territories

A few of the key territories for collagens pipeline products are the US, Europe, China, Israel, and Taiwan. As of December 2023, the US accounted for the highest number of pipeline products.

Collagens Pipeline Market Analysis by Territories, 2023 (%)

Collagens Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Collagens Pipeline Market

Download a Free Report Sample

Collagens Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths followed by the collagens pipeline market are 510(k), CE, NMPA, and BOPA. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Collagens Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Collagens Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Collagens Pipeline Market

Download a Free Report Sample

Collagens Pipeline Market – Competitive Landscape

A few of the key companies associated with the collagens pipeline market are Acro Biomedical Co Ltd, Advanced Biotech Products Pvt Ltd, Advanced Medical Solutions Group plc, AGAM Biological Products, and Altach AG, among others.

Advanced Medical Solutions Group plc: Advanced Medical Solutions Group plc is headquartered in Winsford, Cheshire, the UK. It is a medical technology company that designs, manufactures, and distributes wound care dressings and medical adhesives. The company’s products include tissue adhesives, collagen, sutures, and oxidized cellulose, among others. These products are supplied through major wound care partners and private label distributors. Besides the UK, the company operates in the Netherlands, France, Germany, the Czech Republic, Israel, and Russia.

AGAM Biological Products: AGAM is headquartered in Nes Ziona, Israel. It is a biotechnology company that provides collagen-based wound dressing, skin substitutes, matri-sea plate products, and others. The company also provides services such as collagen research, biochemistry, plastic and reconstructive surgery, and business development services, among others. It caters to medical, cosmetic, nutritional industries, among others.

Collagens Pipeline Market Analysis by Companies, 2023

Collagens Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Collagens Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Collagens Pipeline Market Segments Outlook

  • Antimicrobial Collagen Dressings
  • Non-Antimicrobial Collagen Dressings

Collagens Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Israel
  • Taiwan

Collagens Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • BOPA

Scope

This report provides:

  • Extensive coverage of the Collagens under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of collagens and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of collagens under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acro Biomedical Co Ltd
Advanced Biotech Products Pvt Ltd
Advanced Medical Solutions Group plc
AGAM Biological Products
Altach AG
Altrazeal Life Sciences Inc
Baxter International Inc
Biovotec AS
Collagen Solutions Ltd
Collplant Biotechnologies Ltd
Colzyx AB
Conversion Energy Enterprises
Covalon Technologies Ltd
Ension, Inc.
EternoGen Aesthetics LLC
Gene Biotherapeutics Inc
GeniPhys LLC
Giant Biogene Holding Co Ltd
Harbor MedTech Inc
Holista CollTech Ltd
Innocoll Technologies Ltd (Inactive)
Jellagen Ltd
Keranetics LLC
Lattice Biologics Ltd
Leader Biomedical Europe BV
Medtronic Plc
Michigan State University
MiMedx Group Inc
Nanotherapeutics Inc (Inactive)
Orbsen Therapeutics Ltd
PlasMedica Technologies Limited
Purdue University
Qinghai Chuangming Medical Equipment Co Ltd
Shire Pharmaceuticals International UC
Tel Aviv University
VA Palo Alto Health Care System
Wound Care Innovations LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 9

2 Introduction 10

2.1 Collagens Overview 10

3 Products under Development 11

3.1 Collagens – Pipeline Products by Stage of Development 11

3.2 Collagens – Pipeline Products by Segment 12

3.3 Collagens – Pipeline Products by Territory 13

3.4 Collagens – Pipeline Products by Regulatory Path 14

3.5 Collagens – Pipeline Products by Estimated Approval Date 15

3.6 Collagens – Ongoing Clinical Trials 16

4 Collagens – Pipeline Products under Development by Companies 17

4.1 Collagens Companies – Pipeline Products by Stage of Development 17

4.2 Collagens – Pipeline Products by Stage of Development 19

5 Collagens Companies and Product Overview 21

5.1 Acro Biomedical Co Ltd Company Overview 21

5.1.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Advanced Biotech Products Pvt Ltd Company Overview 22

5.2.1 Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Advanced Medical Solutions Group plc Company Overview 23

5.3.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 AGAM Biological Products Company Overview 24

5.4.1 AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Altach AG Company Overview 25

5.5.1 Altach AG Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Altrazeal Life Sciences Inc Company Overview 26

5.6.1 Altrazeal Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Baxter International Inc Company Overview 27

5.7.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Biovotec AS Company Overview 28

5.8.1 Biovotec AS Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Collagen Solutions Ltd Company Overview 29

5.9.1 Collagen Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Collplant Biotechnologies Ltd Company Overview 30

5.10.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Colzyx AB Company Overview 31

5.11.1 Colzyx AB Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Conversion Energy Enterprises Company Overview 32

5.12.1 Conversion Energy Enterprises Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 Covalon Technologies Ltd Company Overview 33

5.13.1 Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Ension, Inc. Company Overview 35

5.14.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

5.15 EternoGen Aesthetics LLC Company Overview 36

5.15.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 36

5.16 Gene Biotherapeutics Inc Company Overview 37

5.16.1 Gene Biotherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 GeniPhys LLC Company Overview 38

5.17.1 GeniPhys LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.18 Giant Biogene Holding Co Ltd Company Overview 39

5.18.1 Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.19 Harbor MedTech Inc Company Overview 40

5.19.1 Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.20 Holista CollTech Ltd Company Overview 45

5.20.1 Holista CollTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 Innocoll Technologies Ltd (Inactive) Company Overview 46

5.21.1 Innocoll Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 Jellagen Ltd Company Overview 49

5.22.1 Jellagen Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.23 Keranetics LLC Company Overview 50

5.23.1 Keranetics LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.24 Lattice Biologics Ltd Company Overview 51

5.24.1 Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.25 Leader Biomedical Europe BV Company Overview 53

5.25.1 Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview 53

5.26 Medtronic Plc Company Overview 54

5.26.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 54

5.27 Michigan State University Company Overview 56

5.27.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 56

5.28 MiMedx Group Inc Company Overview 57

5.28.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.29 Nanotherapeutics Inc (Inactive) Company Overview 58

5.29.1 Nanotherapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58

5.30 Orbsen Therapeutics Ltd Company Overview 59

5.30.1 Orbsen Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

5.31 PlasMedica Technologies Limited Company Overview 60

5.31.1 PlasMedica Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 60

5.32 Purdue University Company Overview 61

5.32.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 61

5.33 Qinghai Chuangming Medical Equipment Co Ltd Company Overview 62

5.33.1 Qinghai Chuangming Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.34 Shire Pharmaceuticals International UC Company Overview 65

5.34.1 Shire Pharmaceuticals International UC Pipeline Products & Ongoing Clinical Trials Overview 65

5.35 Tel Aviv University Company Overview 66

5.35.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 66

5.36 VA Palo Alto Health Care System Company Overview 67

5.36.1 VA Palo Alto Health Care System Pipeline Products & Ongoing Clinical Trials Overview 67

5.37 Wound Care Innovations LLC Company Overview 68

5.37.1 Wound Care Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 68

6 Collagens- Recent Developments 70

6.1 Dec 08, 2023: OCM Wound Platform Demonstrates Antibacterial Activity in Porcine Wound Model, Significantly Reducing Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Aeruginosa (PA) Compared to Comparator and Control Groups 70

6.2 Dec 08, 2023: OCM Wound Platform Demonstrates Antibacterial Activity in Porcine Wound Model, Significantly Reducing Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Aeruginosa (PA) Compared to Comparator and Control Groups 71

6.3 Dec 06, 2023: Maxigen Biotech Receives 510(K) Clearance For HealiAid Dental Collagen Wound Dressing 72

6.4 Dec 06, 2023: New Clinical Data Demonstrate 90 Percent Area Reduction in Diabetic Foot Ulcers within 12 Weeks or less Using Novel Omeza Platform plus Offloading 72

6.5 Nov 30, 2023: Sanara MedTech Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX Surgical Powder) Was Used to Promote Wound Healing 73

6.6 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 73

6.7 Oct 03, 2023: Baxter Appoints Joel Grade Chief Financial Officer 74

6.8 Oct 02, 2023: Advanced Medical Solutions Group Announces Appointment of New Chair 74

6.9 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors 75

6.10 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 75

6.11 Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million 75

6.12 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 79

6.13 Aug 10, 2023: Advanced Medical Solutions Group Notice of Interim Results 79

6.14 Aug 09, 2023: Collplant Biotechnologies Announces Date for 2023 Second Quarter Financial Results and Conference Call Information 79

6.15 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 80

6.16 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 80

6.17 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO 81

6.18 Jun 26, 2023: Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida 82

6.19 Jun 13, 2023: Breakthrough Solution for Fragile Skin: Covalon’s IV Clear Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of Excellence 82

6.20 May 24, 2023: CollPlant Biotechnologies announces first quarter financial results for 2023 and provides corporate update 83

6.21 May 16, 2023: Covalon, leader in compassionate pediatric infection prevention solutions, to participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 – 19, 2023 85

6.22 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 86

6.23 Apr 28, 2023: Kerecis launches new MariGen Shield to treat wounds 86

6.24 Apr 12, 2023: Medtronic has a layoff in California 87

6.25 Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director 87

6.26 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format 88

6.27 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting 88

6.28 Mar 20, 2023: Leader in compassionate care infection prevention solutions, Covalon, to participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023 89

6.29 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 90

6.30 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022 90

6.31 Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders 92

6.32 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results 92

7 Appendix 95

7.1 Methodology 95

7.2 About GlobalData 98

7.3 Contact Us 98

7.4 Disclaimer 98

Table

Collagens – Pipeline Products by Stage of Development 11

Collagens – Pipeline Products by Segment 12

Collagens – Pipeline Products by Territory 13

Collagens – Pipeline Products by Regulatory Path 14

Collagens – Pipeline Products by Estimated Approval Date 15

Collagens – Ongoing Clinical Trials 16

Collagens Companies – Pipeline Products by Stage of Development 17

Collagens – Pipeline Products by Stage of Development 19

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

ABCcolla Collagen Matrix Powder – Product Status 21

ABCcolla Collagen Matrix Powder – Product Description 21

Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Surgicoll-Mesh – Product Status 22

Surgicoll-Mesh – Product Description 22

Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23

Reinforced Collagen – Product Status 23

Reinforced Collagen – Product Description 23

AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview 24

Wound Dressing Pad – Product Status 24

Wound Dressing Pad – Product Description 24

Altach AG Pipeline Products & Ongoing Clinical Trials Overview 25

Collagen Scaffold – Product Status 25

Collagen Scaffold – Product Description 25

Altrazeal Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Altrazeal Collagen – Product Status 26

Altrazeal Collagen – Product Description 26

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Veritas – Cardiac Application – Product Status 27

Veritas – Cardiac Application – Product Description 27

Biovotec AS Pipeline Products & Ongoing Clinical Trials Overview 28

DermaRep – Product Status 28

DermaRep – Product Description 28

Collagen Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Fibrillar Collagen – Product Status 29

Fibrillar Collagen – Product Description 29

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Vergenix SW – Product Status 30

Vergenix SW – Product Description 30

Colzyx AB Pipeline Products & Ongoing Clinical Trials Overview 31

WOUNDCOM – Product Status 31

WOUNDCOM – Product Description 31

Conversion Energy Enterprises Pipeline Products & Ongoing Clinical Trials Overview 32

Photoactivated Collagen Dressing – Product Status 32

Photoactivated Collagen Dressing – Product Description 32

Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Hemostatic Delivering FNS – Product Status 33

Hemostatic Delivering FNS – Product Description 33

Hemostatic Dressing Delivering PLT – Product Status 34

Hemostatic Dressing Delivering PLT – Product Description 34

Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

Regenerative Collagen Matrix – Product Status 35

Regenerative Collagen Matrix – Product Description 35

EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 36

Collagen Scaffold – Wound Healing – Product Status 36

Collagen Scaffold – Wound Healing – Product Description 36

Gene Biotherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Excellagen – Expanded Structural And Functional Properties – Product Status 37

Excellagen – Expanded Structural And Functional Properties – Product Description 37

GeniPhys LLC Pipeline Products & Ongoing Clinical Trials Overview 38

Tissue Filler – Product Status 38

Tissue Filler – Product Description 38

Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Recombinant Collagen Gynecological Repair Dressing – Product Status 39

Recombinant Collagen Gynecological Repair Dressing – Product Description 39

Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 40

BPMatrix – Achilles Tendons – Product Status 40

BPMatrix – Achilles Tendons – Product Description 41

BPMatrix – Breast Reconstruction – Product Status 41

BPMatrix – Breast Reconstruction – Product Description 41

BPMatrix – Hernia Repair – Product Status 42

BPMatrix – Hernia Repair – Product Description 42

EPMatrix – Torn Ligaments – Product Status 42

EPMatrix – Torn Ligaments – Product Description 43

Extracellular Matrix – Joint Repair – Product Status 43

Extracellular Matrix – Joint Repair – Product Description 43

Extracellular Matrix – Urogynecological Repair – Product Status 44

Extracellular Matrix – Urogynecological Repair – Product Description 44

Holista CollTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Ovicoll M – Product Status 45

Ovicoll M – Product Description 45

Innocoll Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

Collieva Ag – Product Status 46

Collieva Ag – Product Description 46

DermaSIL (CM003) – Product Status 47

DermaSIL (CM003) – Product Description 47

Durieva – Product Status 47

Durieva – Product Description 48

Jellagen Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Collagen-Based Wound Healing Device – Product Status 49

Collagen-Based Wound Healing Device – Product Description 49

Keranetics LLC Pipeline Products & Ongoing Clinical Trials Overview 50

KeraStat Cream – Cutaneous Radiation Injury (CRI) – Product Status 50

KeraStat Cream – Cutaneous Radiation Injury (CRI) – Product Description 50

Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Next Generation Admatrix Dermal Scaffold – Product Status 51

Next Generation Admatrix Dermal Scaffold – Product Description 52

Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview 53

Collagen Dermis – Product Status 53

Collagen Dermis – Product Description 53

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 54

Duratech – Abdominal Wall Reconstruction – Product Status 54

Duratech – Abdominal Wall Reconstruction – Product Description 54

Duratech – Wound Care – Product Status 55

Duratech – Wound Care – Product Description 55

Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 56

Biopolymer Wound Dressing – Product Status 56

Biopolymer Wound Dressing – Product Description 56

MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Placental Collagen Matrix – Product Status 57

Placental Collagen Matrix – Product Description 57

Nanotherapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58

ntSPONGE – Product Status 58

ntSPONGE – Product Description 58

Orbsen Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

Orbcel – Product Status 59

Orbcel – Product Description 59

PlasMedica Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 60

PlasmaPly – Internal Ulcers – Product Status 60

PlasmaPly – Internal Ulcers – Product Description 60

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 61

Bioscaffold – Soft Tissue Repair – Product Status 61

Bioscaffold – Soft Tissue Repair – Product Description 61

Qinghai Chuangming Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Recombinant Collagen Dressing – Product Status 62

Recombinant Collagen Dressing – Product Description 62

Qinghai Chuangming Medical Equipment Co Ltd – Ongoing Clinical Trials Overview 63

Recombinant Collagen Dressing – A Clinical Trial to Evaluate the Safety and Efficacy of Recombinant Collagen Dressings for Postoperative Wound Repair after Photoelectric Therapy 64

Shire Pharmaceuticals International UC Pipeline Products & Ongoing Clinical Trials Overview 65

Recombinant Collagen VII (rC7) – Product Status 65

Recombinant Collagen VII (rC7) – Product Description 65

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 66

Smart Wound Dressing – Product Status 66

Smart Wound Dressing – Product Description 66

VA Palo Alto Health Care System Pipeline Products & Ongoing Clinical Trials Overview 67

Corneal Reconstruction Collagen Gel – Product Status 67

Corneal Reconstruction Collagen Gel – Product Description 67

Wound Care Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Next Generation CellerateRX – Product Status 68

Next Generation CellerateRX – Product Description 68

Next Generation Hycol – Product Status 69

Next Generation Hycol – Product Description 69

Glossary 97

Figures

Collagens – Pipeline Products by Stage of Development 11

Collagens – Pipeline Products by Segment 12

Collagens – Pipeline Products by Territory 13

Collagens – Pipeline Products by Regulatory Path 14

Collagens – Pipeline Products by Estimated Approval Date 15

Collagens – Ongoing Clinical Trials 16

Frequently asked questions

Collagens Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Collagens Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Collagens Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Collagens Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.